Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NU vs GSK✓SelectedUSD · GSKNU vs GSK performance historyLatest closeAs of-2.15%11/19
Stock and ETF performance explorer

NU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+14.4%
GSK return
+36.0%
Excess return
-21.6%
Maximum drawdown
-72.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.2%-1.6%-0.6%-1.9%
7D-0.1%-4.7%+4.6%+0.8%
30D-21.7%-4.7%-17.0%-21.0%
3M-19.1%-8.8%-10.3%-17.8%
6M-3.8%-4.6%+0.8%-3.2%
YTD-29.4%+1.0%-30.4%-29.6%
1Y-24.5%+6.9%-31.4%-25.5%
3Y+46.5%+52.5%-6.1%+31.3%
All+14.4%+36.0%-21.6%-7.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling